Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion-Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS-2002P and RMS 2005 Studies and the Soft Tissue Sarcoma Registry.
Heinz AT, Ciuffolotti M, Merks JHM, Schönstein A, Minard-Colin V, Fuchs J, Guillen G, Timmermann B, Vokuhl C, Koscielniak E, Chisholm JC, Sparber-Sauer M, Bisogno G. Heinz AT, et al. Among authors: bisogno g. Pediatr Blood Cancer. 2024 Dec 10:e31476. doi: 10.1002/pbc.31476. Online ahead of print. Pediatr Blood Cancer. 2024. PMID: 39655886
Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults.
Sparber-Sauer M, Ferrari A, Kosztyla D, Ladenstein R, Cecchetto G, Kazanowska B, Scarzello G, Ljungman G, Milano GM, Niggli F, Alaggio R, Vokuhl C, Casanova M, Klingebiel T, Zin A, Koscielniak E, Bisogno G. Sparber-Sauer M, et al. Among authors: bisogno g. Pediatr Blood Cancer. 2022 Sep;69(9):e29691. doi: 10.1002/pbc.29691. Epub 2022 Apr 19. Pediatr Blood Cancer. 2022. PMID: 35441463 Clinical Trial.
Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
Mercolini F, Merks JHM, Minard-Colin V, Cameron A, van Scheltinga SEJT, Sher O, Fichera G, Orbach D, Glosli H, Coppadoro B, Gallego S, Chisholm JC, Bisogno G. Mercolini F, et al. Among authors: bisogno g. Pediatr Blood Cancer. 2023 Mar;70(3):e30143. doi: 10.1002/pbc.30143. Epub 2022 Dec 15. Pediatr Blood Cancer. 2023. PMID: 36519598
Metastatic adult-type non-rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group.
Ferrari A, Orbach D, Casanova M, van Noesel MM, Berlanga P, Brennan B, Corradini N, Schoot RA, Ramirez-Villar GL, Hjalgrim LL, Alaggio R, Guillen Burrieza G, Safwat A, Cameron AL, van Rijn RR, Minard-Colin V, Zanetti I, Bisogno G, Chisholm JC, Merks JHM. Ferrari A, et al. Among authors: bisogno g. Cancer. 2023 Aug 15;129(16):2542-2552. doi: 10.1002/cncr.34814. Epub 2023 Apr 21. Cancer. 2023. PMID: 37084075 Free article.
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
De Salvo GL, Del Bianco P, Minard-Colin V, Chisholm J, Jenney M, Guillen G, Devalck C, Van Rijn R, Shipley J, Orbach D, Kelsey A, Rogers T, Guerin F, Scarzello G, Ferrari A, Cesen Mazic M, Merks JHM, Bisogno G; European Pediatric Soft Tissue Sarcoma Study Group. De Salvo GL, et al. Among authors: bisogno g. Cancer. 2024 Jul 1;130(13):2351-2360. doi: 10.1002/cncr.35258. Epub 2024 Feb 24. Cancer. 2024. PMID: 38400828 Free PMC article.
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.
Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G; RARECAREnet Working Group. Ferrari A, et al. Among authors: bisogno g. Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26348. Epub 2016 Nov 24. Pediatr Blood Cancer. 2017. PMID: 27882658
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Gallego S, Zanetti I, Orbach D, Ranchère D, Shipley J, Zin A, Bergeron C, de Salvo GL, Chisholm J, Ferrari A, Jenney M, Mandeville HC, Rogers T, Merks JHM, Mudry P, Glosli H, Milano GM, Ferman S, Bisogno G; European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Gallego S, et al. Among authors: bisogno g. Cancer. 2018 Aug 1;124(15):3201-3209. doi: 10.1002/cncr.31553. Epub 2018 May 24. Cancer. 2018. PMID: 29797665 Free article.
347 results